1,966 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 799 increasing their positions, 755 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding:

more ownership

Funds ownership:

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.16B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,966
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
253
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$1.79B
Puts
$2.95B
Net Calls
Net Calls Change

Top Buyers

1 +$588M
2 +$433M
3 +$411M
4
CM
Corvex Management
New York
+$391M
5
Sanders Capital
Sanders Capital
Florida
+$331M

Top Sellers

1 -$1.43B
2 -$1.39B
3 -$1.31B
4
Franklin Resources
Franklin Resources
California
-$677M
5
Bank of New York Mellon
Bank of New York Mellon
New York
-$368M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$251M
102
$250M
103
$250M
104
$244M
105
$240M
106
$236M
107
$233M
108
$233M
109
$232M
110
$225M
111
$212M
112
$211M
113
$210M
114
$206M
115
$206M
116
$206M
117
$203M
118
$196M
119
$195M
120
$193M
121
$192M
122
$190M
123
$188M
124
$188M
125
$186M